Latest News & Features
Patents
Korean pharmaceutical, biotech, and life sciences companies are actively expanding globally, leading to more complex and multifaceted IP strategies than in the past. 29 October 2024
Patents
How to foster effective collaboration between academia and industry?
Best practices for bridging that gap between the two spheres
Technology transfer
How to leverage academic research for commercialization 29 October 2024
Patents
The Unified Patent Court (UPC) opened for business in June 2023. In this session, we will look at how UPC litigation has been shaping up over the last year, including practical tips based on our experiences so far. 29 October 2024
Patents
In this session, Will James and Tim Harris will discuss their personal experiences litigating life sciences cases before the UPC. They will share their substantive and procedural insights, as well as strategic considerations and pitfalls to avoid. 29 October 2024
Patents
Join us as we delve into the complexities of international harmonization and global patent strategies in the ever-evolving landscape of IP rights. 29 October 2024
Copyright
A court’s decision in favour of a software company is set to have a ripple effect on cases relating to fair use and artificial intelligence. Marisa Woutersen spoke to the winning counsel to find out more. 29 October 2024
Unified Patent Court
German company files suit against chipmaker at the UPC in Munich | Case marks chipmaker’s first major dispute at the pan-European court | Suit follows Nvidia’s emergence as the world’s most valuable company and Microsoft dispute in the US. 29 October 2024
Patents
Agreement halts all litigation in multiple jurisdictions between the pair | US company agrees to pay royalties to the Finnish telecoms giant for using video technology in its devices. 29 October 2024
Copyright
Member states cannot apply material reciprocity clause in Berne Convention following judgment | Decision relates to dispute over iconic Eames-designed chair 28 October 2024
Patents
A federal jury finds Masimo’s smartwatches infringe Apple’s blood oxygen patents | Decision results in an award of just $250 for the tech giant | Despite the victory, Masimo says the ruling does not apply to its current products. 28 October 2024
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.